JPH10167941A - Composition for oral cavity containing biologically active glass - Google Patents
Composition for oral cavity containing biologically active glassInfo
- Publication number
- JPH10167941A JPH10167941A JP35203496A JP35203496A JPH10167941A JP H10167941 A JPH10167941 A JP H10167941A JP 35203496 A JP35203496 A JP 35203496A JP 35203496 A JP35203496 A JP 35203496A JP H10167941 A JPH10167941 A JP H10167941A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- weight
- bioactive glass
- glass
- biologically active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 210000000214 mouth Anatomy 0.000 title claims description 4
- 239000011521 glass Substances 0.000 title abstract description 21
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 claims abstract description 12
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 claims abstract description 10
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims abstract description 9
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940011037 anethole Drugs 0.000 claims abstract description 6
- 229910010272 inorganic material Inorganic materials 0.000 claims abstract description 6
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 claims abstract description 6
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 claims abstract description 5
- 239000005973 Carvone Substances 0.000 claims abstract description 5
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 5
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 claims abstract description 5
- 150000002484 inorganic compounds Chemical class 0.000 claims abstract description 5
- 229940041616 menthol Drugs 0.000 claims abstract description 5
- 229930007503 menthone Natural products 0.000 claims abstract description 5
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims abstract description 4
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000005770 Eugenol Substances 0.000 claims abstract description 4
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229960005233 cineole Drugs 0.000 claims abstract description 4
- 229960002217 eugenol Drugs 0.000 claims abstract description 4
- 229960001047 methyl salicylate Drugs 0.000 claims abstract description 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract 2
- 239000005313 bioactive glass Substances 0.000 claims description 27
- 229910004298 SiO 2 Inorganic materials 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 3
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 claims 1
- 239000000606 toothpaste Substances 0.000 abstract description 11
- 229940034610 toothpaste Drugs 0.000 abstract description 11
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 abstract description 10
- 229910052588 hydroxylapatite Inorganic materials 0.000 abstract description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 7
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 4
- 229930007050 cineol Natural products 0.000 abstract description 3
- 239000002324 mouth wash Substances 0.000 abstract description 3
- 229940051866 mouthwash Drugs 0.000 abstract description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 abstract 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 abstract 2
- 229910018404 Al2 O3 Inorganic materials 0.000 abstract 1
- 229910015133 B2 O3 Inorganic materials 0.000 abstract 1
- 229910004865 K2 O Inorganic materials 0.000 abstract 1
- 229910011763 Li2 O Inorganic materials 0.000 abstract 1
- 229910004742 Na2 O Inorganic materials 0.000 abstract 1
- 229910004554 P2 O5 Inorganic materials 0.000 abstract 1
- 229910052681 coesite Inorganic materials 0.000 abstract 1
- 229910052906 cristobalite Inorganic materials 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 229910052682 stishovite Inorganic materials 0.000 abstract 1
- 229910052905 tridymite Inorganic materials 0.000 abstract 1
- -1 calcium phosphate compound Chemical class 0.000 description 25
- 235000014113 dietary fatty acids Nutrition 0.000 description 17
- 239000000194 fatty acid Substances 0.000 description 17
- 229930195729 fatty acid Natural products 0.000 description 17
- 229910052586 apatite Inorganic materials 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 7
- 210000000988 bone and bone Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000002280 amphoteric surfactant Substances 0.000 description 4
- 230000000975 bioactive effect Effects 0.000 description 4
- 238000004040 coloring Methods 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 210000003298 dental enamel Anatomy 0.000 description 3
- 239000000551 dentifrice Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 description 2
- 229910018068 Li 2 O Inorganic materials 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229910010413 TiO 2 Inorganic materials 0.000 description 2
- 239000003082 abrasive agent Substances 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- JOZKFWLRHCDGJA-UHFFFAOYSA-N citronellol acetate Chemical compound CC(=O)OCCC(C)CCC=C(C)C JOZKFWLRHCDGJA-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229940085605 saccharin sodium Drugs 0.000 description 2
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 238000004017 vitrification Methods 0.000 description 2
- 229910052882 wollastonite Inorganic materials 0.000 description 2
- 239000010456 wollastonite Substances 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- KRLBLPBPZSSIGH-CSKARUKUSA-N (6e)-3,7-dimethylnona-1,6-dien-3-ol Chemical compound CC\C(C)=C\CCC(C)(O)C=C KRLBLPBPZSSIGH-CSKARUKUSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- AXCXHFKZHDEKTP-NSCUHMNNSA-N 4-methoxycinnamaldehyde Chemical compound COC1=CC=C(\C=C\C=O)C=C1 AXCXHFKZHDEKTP-NSCUHMNNSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 239000000120 Artificial Saliva Substances 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 239000004604 Blowing Agent Substances 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- JOZKFWLRHCDGJA-LLVKDONJSA-N Citronellyl acetate Natural products CC(=O)OCC[C@H](C)CCC=C(C)C JOZKFWLRHCDGJA-LLVKDONJSA-N 0.000 description 1
- 241000270722 Crocodylidae Species 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N Na2O Inorganic materials [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- GEIAQOFPUVMAGM-UHFFFAOYSA-N ZrO Inorganic materials [Zr]=O GEIAQOFPUVMAGM-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000012237 artificial material Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 239000000316 bone substitute Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- LNNWVNGFPYWNQE-GMIGKAJZSA-N desomorphine Chemical compound C1C2=CC=C(O)C3=C2[C@]24CCN(C)[C@H]1[C@@H]2CCC[C@@H]4O3 LNNWVNGFPYWNQE-GMIGKAJZSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229940116837 methyleugenol Drugs 0.000 description 1
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 150000007823 ocimene derivatives Chemical class 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- AXCXHFKZHDEKTP-UHFFFAOYSA-N para-methoxycinnamaldehyde Natural products COC1=CC=C(C=CC=O)C=C1 AXCXHFKZHDEKTP-UHFFFAOYSA-N 0.000 description 1
- KFHHGNBIPJDZPH-UHFFFAOYSA-D pentamagnesium [oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O KFHHGNBIPJDZPH-UHFFFAOYSA-D 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960000414 sodium fluoride Drugs 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 1
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- XJPBRODHZKDRCB-UHFFFAOYSA-N trans-alpha-ocimene Natural products CC(=C)CCC=C(C)C=C XJPBRODHZKDRCB-UHFFFAOYSA-N 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、歯牙表面にハイド
ロキシアパタイト膜を形成する口腔用組成物に関する。The present invention relates to an oral composition for forming a hydroxyapatite film on a tooth surface.
【0002】[0002]
【従来技術】人工材料を骨の欠損部に埋入すると、生体
で防御反応が起こることが知られているが、ガラス、セ
ラミックスの中には生体組織と自然に結合するものがあ
り、これらは生体活性材料と称される。生体活性能をも
つ生体活性ガラスもその一種であり、すでに人工骨や人
工歯根として用いられている。2. Description of the Related Art It is known that when an artificial material is implanted into a bone defect, a protective reaction occurs in a living body. However, some glasses and ceramics naturally bind to living tissue. It is called a bioactive material. Bioactive glass having bioactivity is one of them, and is already used as an artificial bone or an artificial tooth root.
【0003】これらの生体活性ガラスは、そのガラス中
にアパタイトやウォラストナイトなどの結晶を含む生体
活性結晶化ガラスと、そのような結晶を含まない通常の
生体活性ガラスとに大別できる。例えば、特公昭62−
10939号公報には、アパタイトおよびウォラストナ
イト結晶を含む人工骨用結晶化ガラスとその製造法が開
示されており、その結晶化ガラスが生体親和性に優れ、
骨と直接化学結合を形成し、機械的強度にも優れること
が記載されている。[0003] These bioactive glasses can be broadly classified into bioactive crystallized glass containing crystals such as apatite and wollastonite in the glass, and ordinary bioactive glass containing no such crystals. For example,
No. 10939 discloses a crystallized glass for artificial bone containing apatite and wollastonite crystals and a method for producing the same. The crystallized glass has excellent biocompatibility,
It describes that it forms a chemical bond directly with bone and has excellent mechanical strength.
【0004】また、特開平6−30984号公報には、
CaOとSiO2を主成分とするガラスまたは結晶化ガ
ラスからなる人工骨において、ガラス表面に疎水基を結
合させてCa2+イオンの溶出量を調節することにより、
ガラスの強度劣化を防止する技術が開示されている。特
開平5−31166号公報には、チタンなどの金属に生
体活性ガラスをコーティングし、骨補填材として用いる
技術が開示されている。[0004] Japanese Patent Application Laid-Open No. 6-30984 discloses that
In artificial bone made of glass or crystallized glass containing CaO and SiO 2 as main components, by adjusting the amount of Ca 2+ ions eluted by binding a hydrophobic group to the glass surface,
There is disclosed a technique for preventing deterioration of glass strength. JP-A-5-31166 discloses a technique in which a metal such as titanium is coated with a bioactive glass and used as a bone replacement material.
【0005】さらに、特開平2−255515号公報に
は、生体活性ガラスを用いて、無機材料、金属材料、有
機材料を問わず、骨修復材料、体内埋め込み式医療器具
器材、医療用品、人工臓器など、生体中で使われる全て
の材料の表面に、生体内の骨と類似の生体活性アパタイ
ト膜を形成させる方法が開示されている。[0005] Further, Japanese Patent Application Laid-Open No. 2-255515 discloses that bone-repair materials, implantable medical instruments and equipment, medical supplies, artificial organs using bioactive glass regardless of inorganic materials, metallic materials, and organic materials. For example, a method of forming a bioactive apatite film similar to bone in a living body on the surface of all materials used in the living body is disclosed.
【0006】一方、口腔剤分野においては、リン酸カル
シウム系の化合物を用いて歯牙表面にハイドロキシアパ
タイト膜を形成させることが公知であり、例えば、難溶
性のハイドロキシアパタイトにNaCl、KCl、Mg
Cl2などの塩化物を添加し、水に対する溶解度を増大
させることによって歯牙表面をコーティングする技術
(特開昭56−73015号公報)などが知られてい
る。また、炭酸アパタイトを中性または弱アルカリ性の
条件下でハイドロキシアパタイトに転化させる(特開昭
64−70408号公報)技術や、カルシウム塩を含有
した歯磨組成物を口腔内で水(唾液)の存在下にハイド
ロキシアパタイトに転化させる(特開平7−22930
号公報)技術などが開示されている。しかしながら、こ
のような現状の口腔用組成物では、短時間で歯牙表面を
均一にコーティングできず、よって有効な虫歯予防効果
を奏することができない。[0006] On the other hand, in the field of oral preparations, it is known to form a hydroxyapatite film on the tooth surface using a calcium phosphate compound. For example, NaCl, KCl, Mg
A technique of adding a chloride such as Cl 2 to increase the solubility in water to coat the tooth surface (Japanese Patent Application Laid-Open No. 56-73015) is known. Further, a technique for converting carbonate apatite into hydroxyapatite under neutral or weakly alkaline conditions (Japanese Patent Laid-Open No. 70408/1988), or a method for converting a dentifrice composition containing a calcium salt into water (saliva) in the oral cavity. Underneath, it is converted to hydroxyapatite (JP-A-7-22930)
Publication) technology is disclosed. However, such a current oral composition cannot uniformly coat the tooth surface in a short period of time, and thus cannot exhibit an effective caries prevention effect.
【0007】[0007]
【発明が解決しようとする課題】生体活性ガラスは、唾
液中で短時間でアパタイトに転化するため、口腔剤に用
いると、短時間で歯牙表面を均一にコーティングでき
る。ところが、生体活性ガラスを含有する口腔剤組成物
では、経時で着色するなどの問題がある。Since bioactive glass is converted into apatite in saliva in a short time, it can be uniformly coated on a tooth surface in a short time when used in an oral preparation. However, the oral composition containing bioactive glass has problems such as coloring over time.
【0008】[0008]
【課題を解決するための手段】本発明者は、上記の問題
点を解決すべく鋭意検討した結果、生体活性ガラス含有
口腔剤組成物に特定の化合物を加えると、着色が防止で
きることを見出し、本発明を完成するに至った。Means for Solving the Problems The present inventors have conducted intensive studies to solve the above-mentioned problems, and as a result, have found that coloring can be prevented by adding a specific compound to a bioactive glass-containing oral composition. The present invention has been completed.
【0009】すなわち、本発明は、生体活性ガラスの1
種または2種以上、アネトール、カルボン、メントー
ル、オイゲノール、シネオール、メントン、サリチル酸
メチルから選ばれる1種以上を配合した口腔用組成物を
提供するものである。That is, the present invention provides one of the bioactive glasses.
An object of the present invention is to provide an oral composition containing one or more species selected from the group consisting of one or more anethole, carvone, menthol, eugenol, cineol, menthone, and methyl salicylate.
【0010】[0010]
【発明の実施の形態】本発明に用いる生体活性ガラス
は、歯牙表面と自然に結合するガラス材料であれば限定
されるものではなく、そのガラス中に結晶を含有する生
体活性結晶化ガラス、あるいはそのような結晶を含有し
ない通常の生体活性ガラスのいずれであってもよい。生
体活性ガラスの組成は、ガラス全体に対してSiO2を
20〜70重量%、CaOを10〜60重量%含有する
のが好ましく、特に、SiO2を30〜60重量%、C
aOを10〜50重量%およびNa2Oを0〜30重量
%含有するのが好ましい。ガラス中のSiO2が20重
量%に満たないと歯牙表面との親和性が低下し、一方、
70重量%を超えるとガラス化が困難となるため好まし
くない。また、ガラス中のCaOが10重量%に満たな
いと歯牙表面との親和性が低下し、一方、60重量%を
超えるとガラス化が困難となるため好ましくない。Na
2Oはガラスを低融性とするが、30重量%を超えると
歯牙表面との親和性が低下するため好ましくない。DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The bioactive glass used in the present invention is not limited as long as it is a glass material that naturally bonds to the tooth surface, and bioactive crystallized glass containing crystals in the glass, or Any of the usual bioactive glasses that do not contain such crystals may be used. The composition of the bioactive glass preferably contains 20 to 70% by weight of SiO 2 and 10 to 60% by weight of CaO based on the whole glass, and particularly, 30 to 60% by weight of SiO 2 and C
preferably contains 0-30 wt% 10 to 50 wt% and Na 2 O to aO-. If the content of SiO 2 in the glass is less than 20% by weight, the affinity with the tooth surface decreases, while
If it exceeds 70% by weight, vitrification becomes difficult, which is not preferable. If the content of CaO in the glass is less than 10% by weight, the affinity for the tooth surface is reduced, while if it exceeds 60% by weight, vitrification becomes difficult, which is not preferable. Na
2 O is a TeiTorusei the glass, but not preferred to lower the affinity exceeds the tooth surface 30 wt%.
【0011】本発明では、これら生体活性ガラスの1種
または2種以上を用いることができ、その配合量は、組
成物全体に対して0.001〜50重量%である。配合
量が0.001重量%に満たないと歯牙表面にアパタイ
トが形成されず、一方、50重量%を超えると歯牙表面
を損傷するため好ましくない。In the present invention, one or more of these bioactive glasses can be used, and the compounding amount thereof is 0.001 to 50% by weight based on the whole composition. If the amount is less than 0.001% by weight, apatite is not formed on the tooth surface, while if it exceeds 50% by weight, the tooth surface is damaged, which is not preferable.
【0012】さらに、本発明に用いる生体活性ガラスで
は、P2O5、K2O、Li2O、TiO2、Al2O3、M
gO、B2O3、ZrO2、およびFよりなる群から選択
される1種または2種以上の無機化合物を含有させるこ
とができる。これらの無機化合物のうち、P2O5はガラ
スを安定化し、K2O、Li2OおよびB2O3はガラスを
低融性とし、TiO2、Al2O3、MgO、ZrO2およ
びFはアパタイトのコーティング速度を調節するよう作
用する。これらの無機化合物は、生体活性ガラス組成中
に0〜30重量%を含有させることができる。Further, in the bioactive glass used in the present invention, P 2 O 5 , K 2 O, Li 2 O, TiO 2 , Al 2 O 3 , M
One or more inorganic compounds selected from the group consisting of gO, B 2 O 3 , ZrO 2 , and F can be contained. Among these inorganic compounds, P 2 O 5 stabilizes the glass, K 2 O, Li 2 O and B 2 O 3 make the glass low-melting, TiO 2 , Al 2 O 3 , MgO, ZrO 2 and F acts to adjust the coating rate of apatite. These inorganic compounds can be contained in the bioactive glass composition in an amount of 0 to 30% by weight.
【0013】本発明に用いる生体活性ガラスは、球状、
ビーズ状、粒状、顆粒状などの形状を有しており、例え
ば、特開昭60−239341号公報などに開示される
方法に基づいて製造できる。また、生体活性ガラスは、
32メッシュパス未満のものが好適に用いられ、65メ
ッシュパスが特に好ましい。大きさが32メッシュ以上
となると口腔用組成物の使用感が損なわれるため好まし
くない。The bioactive glass used in the present invention is spherical,
It has a bead shape, a granular shape, a granular shape, and the like, and can be produced based on a method disclosed in, for example, Japanese Patent Application Laid-Open No. 60-239341. Also, bioactive glass is
Those with less than 32 mesh passes are suitably used, with 65 mesh passes being particularly preferred. When the size is 32 mesh or more, the feeling of use of the oral composition is impaired, which is not preferable.
【0014】本発明の口腔用組成物は、アネトール、カ
ルボン、メントール、オイゲノール、シネオール、メン
トン、サリチル酸メチルから選ばれる1種以上を含有す
る。それらの配合量は、限定されるものではないが、特
に合計の配合量で0.001〜5重量%が好ましく、
0.005〜2重量%が最も好ましい。また、本発明の
口腔用組成物はpH3〜10で、特にハイドロキシアパ
タイトの形成性に優れており、必要に応じクエン酸、リ
ン酸、リンゴ酸、ピロリン酸、乳酸、酒石酸、グリセロ
リン酸、酢酸、硝酸、あるいはその塩、水酸化ナトリウ
ム、トリエタノールアミンなどのpH調整剤を用いても
よい。The oral composition of the present invention contains at least one selected from anethole, carvone, menthol, eugenol, cineol, menthone, and methyl salicylate. The blending amount thereof is not limited, but it is particularly preferably 0.001 to 5% by weight in total.
0.005 to 2% by weight is most preferred. Further, the oral composition of the present invention has a pH of 3 to 10 and is particularly excellent in forming hydroxyapatite. If necessary, citric acid, phosphoric acid, malic acid, pyrophosphoric acid, lactic acid, tartaric acid, glycerophosphoric acid, acetic acid, A pH adjuster such as nitric acid or a salt thereof, sodium hydroxide, and triethanolamine may be used.
【0015】本発明の口腔用組成物は、練歯磨、粉歯
磨、液状歯磨などの歯磨、洗口液、ジェルなどの形態で
提供できる。本発明の組成物では、それぞれの形態に応
じ、研磨剤、発泡剤、香味剤、甘味剤、粘結剤、薬効成
分などを、適宜、発明の効果を損なわない範囲で配合す
ることができる。The oral composition of the present invention can be provided in the form of toothpaste such as toothpaste, powdered toothpaste, liquid toothpaste, mouthwash, gel and the like. In the composition of the present invention, an abrasive, a foaming agent, a flavoring agent, a sweetening agent, a binder, a medicinal ingredient, and the like can be appropriately blended in a range that does not impair the effects of the present invention.
【0016】研磨剤として、例えば、第二リン酸カルシ
ウム・二水物および無水物、リン酸カルシウム、第三リ
ン酸カルシウム、炭酸カルシウム、ピロリン酸カルシウ
ム、水酸化アルミニウム、アルミナ、無水ケイ酸、シリ
カゲル、ケイ酸アルミニウム、不溶性メタリン酸ナトリ
ウム、第三リン酸マグネシウム、炭酸マグネシウム、硫
酸カルシウム、ポリメタクリル酸メチル、ベントナイ
ト、ケイ酸ジルコニウム、合成樹脂などを用いることが
できる。これらの研磨剤は単独で用いても2種以上を併
用してもよく、その配合量は、通常、組成物全体に対し
て5〜90重量%、練歯磨の場合には5〜60重量%で
ある。Examples of abrasives include dibasic calcium phosphate dihydrate and anhydride, calcium phosphate, tribasic calcium phosphate, calcium carbonate, calcium pyrophosphate, aluminum hydroxide, alumina, silicic anhydride, silica gel, aluminum silicate, and insoluble methaline. Sodium acid, magnesium triphosphate, magnesium carbonate, calcium sulfate, polymethyl methacrylate, bentonite, zirconium silicate, synthetic resin, and the like can be used. These abrasives may be used alone or in combination of two or more. The compounding amount is usually 5 to 90% by weight based on the whole composition, and 5 to 60% by weight in the case of toothpaste. It is.
【0017】発泡剤としては、ショ糖脂肪酸エステル、
マルトース脂肪酸エステル、マルチトール脂肪酸エステ
ル、マルトトリイトール脂肪酸エステル、マルトテトラ
イトール脂肪酸エステル、マルトペンタイトール脂肪酸
エステル、マルトヘキサイトール脂肪酸エステル、マル
トヘプタイトール脂肪酸エステル、ソルビタン脂肪酸エ
ステル、ラクトース脂肪酸エステル、ラクチノース脂肪
酸エステル、ポリオキシエチレンポリオキシプロピレン
共重合体、ポリオキシエチレンアルキルエーテル類、ポ
リオキシエチレン脂肪酸エステル類、脂肪酸アルカノー
ルアミド類、ポリオキシエチレンソルビタン脂肪酸エス
テル類、ポリオキシエチレン硬化ヒマシ油、ポリグリセ
リン脂肪酸脂肪酸エステル類などの非イオン性界面活性
剤、As foaming agents, sucrose fatty acid esters,
Maltose fatty acid ester, maltitol fatty acid ester, maltotriitol fatty acid ester, maltotetriitol fatty acid ester, maltopentitol fatty acid ester, maltohexaitol fatty acid ester, maltoheptitol fatty acid ester, sorbitan fatty acid ester, lactose fatty acid ester , Lactinose fatty acid ester, polyoxyethylene polyoxypropylene copolymer, polyoxyethylene alkyl ethers, polyoxyethylene fatty acid esters, fatty acid alkanolamides, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene hydrogenated castor oil, poly Nonionic surfactants such as glycerin fatty acid fatty acid esters,
【0018】ラウリル硫酸ナトリウム、ミリスチル硫酸
ナトリウムなどのアルキル基の炭素数が8〜18である
高級アルキル硫酸エステルの水溶性塩、ポリオキシエチ
レンアルキル硫酸塩、アルキルスルホ酢酸塩、α−オレ
フィンスルホン酸塩、スルホコハク酸誘導体、高級脂肪
酸ナトリウムモノグリセライドモノサルフェート、N−
メチル−N−パルミトイルタウライド塩、N−長鎖アシ
ル塩基性アミノ酸塩、タウレート誘導体などのアニオン
性界面活性剤があげられる。Water-soluble salts of higher alkyl sulfates having 8 to 18 carbon atoms in the alkyl group, such as sodium lauryl sulfate and sodium myristyl sulfate, polyoxyethylene alkyl sulfates, alkyl sulfoacetates, α-olefin sulfonates , Sulfosuccinic acid derivatives, higher fatty acid sodium monoglyceride monosulfate, N-
Examples include anionic surfactants such as methyl-N-palmitoyl tauride salt, N-long-chain acyl basic amino acid salt, and taurate derivative.
【0019】また、ベタイン型両性界面活性剤、イミダ
ゾリウム型両性界面活性剤、イミダゾリウムベタイン型
両性界面活性剤、カルボン酸型両性界面活性剤などがあ
げられる。これら発泡剤は、単独で用いても2種以上を
併用してもよく、その配合量は、通常、組成物全体に対
して0.1〜10重量%である。Further, there may be mentioned betaine type amphoteric surfactants, imidazolium type amphoteric surfactants, imidazolium betaine type amphoteric surfactants, carboxylic acid type amphoteric surfactants and the like. These blowing agents may be used alone or in combination of two or more, and the compounding amount is usually 0.1 to 10% by weight based on the whole composition.
【0020】粘結剤としては、カルボキシメチルセルロ
ースなどのセルロース誘導体、アルギン酸ナトリウムな
どのアルカリ金属アルギネート、アルギン酸プロピレン
グリコールエステル、ゼラチン、キサンタンガム、トラ
ガカントガム、カラヤガム、アラビアガム、カラギーナ
ンなどのガム類、ポリビニルアルコール、ポリアクリル
酸ナトリウム、カルボキシビニルポリマー、ポリビニル
ピロリドンなどの合成粘結剤、シリカゲル、アルミニウ
ムシリカゲル、ビーガム、ラポナイトなどの無機粘結剤
が挙げられ、これらの粘結剤は、単独で用いても2種以
上を併用してもよく、その配合量は、通常、組成物全体
に対して0.3〜5重量%である。Examples of the binder include cellulose derivatives such as carboxymethylcellulose, alkali metal alginate such as sodium alginate, propylene glycol alginate, gelatin, xanthan gum, tragacanth gum, karaya gum, gum arabic, gum such as carrageenan, polyvinyl alcohol, polyalcohol and the like. Examples include synthetic binders such as sodium acrylate, carboxyvinyl polymer, and polyvinylpyrrolidone, and inorganic binders such as silica gel, aluminum silica gel, veegum, and laponite. These binders may be used alone or in combination of two or more. May be used in combination, and the amount thereof is usually 0.3 to 5% by weight based on the whole composition.
【0021】また、ソルビット、グリセリン、エチレン
グリコール、プロピレングリコール、1,3ーブチレン
グリコール、ポリエチレングリコール、ポリプロピレン
グリコール、マルチット、ラクチットなどの湿潤剤も配
合でき、Also, wetting agents such as sorbit, glycerin, ethylene glycol, propylene glycol, 1,3-butylene glycol, polyethylene glycol, polypropylene glycol, maltite, lactit can be blended.
【0022】シンナミックアルデヒド、リモネン、オシ
メン、n−デシルアルコール、シトロネロール、α−テ
ルピネオール、メチルアセテート、シトロネリルアセテ
ート、メチルオイゲノール、リナロール、エチルリナロ
ール、ワニリン、チモール、スペアミント油、ペパーミ
ント油、レモン油、オレンジ油、セージ油、ローズマリ
ー油、桂皮油、ピメント油、珪藻油、シソ油、冬緑油、
丁子油、ユーカリ油などの香味剤あるいはサッカリンナ
トリウム、アセチルファームカリウム、ステビオサイ
ド、ネオヘスポリジルジヒドロカルコン、グリチルリチ
ン、キシリット、ペリラルチン、タウマチン、アスパル
チルフェニルアラニンメチルエステル、p−メトキシシ
ンナミックアルデヒド、マルチット、ラクチットなどの
甘味剤も配合できる。Cinamic aldehyde, limonene, ocimene, n-decyl alcohol, citronellol, α-terpineol, methyl acetate, citronellyl acetate, methyl eugenol, linalool, ethyl linalool, crocodile, thymol, spearmint oil, peppermint oil, lemon oil, Orange oil, sage oil, rosemary oil, cinnamon oil, pimento oil, diatom oil, perilla oil, winter green oil,
Flavoring agents such as clove oil and eucalyptus oil or saccharin sodium, acetyl farm potassium, stevioside, neohesporidyl dihydrochalcone, glycyrrhizin, xylit, perillartin, thaumatin, aspartyl phenylalanine methyl ester, p-methoxycinnamic aldehyde, maltitol, lactit, etc. Sweetener can also be added.
【0023】また、グルコン酸クロルヘキシジン、塩化
セチルピリジニウム、トリクロサンなどの殺菌剤、デキ
ストラナーゼ、アミラーゼ、プロテアーゼ、ムタナー
ゼ、リゾチーム、溶菌酵素(リテックエンザイム)など
の酵素、モノフルオロリン酸ナトリウム、モノフルオロ
リン酸カリウムなどのアルカリ金属モノフルオロホスフ
ェート、フッ化ナトリウム、フッ化第一スズなどのフッ
化物、ビタミン誘導体、トラネキサム酸およびイプシロ
ンアミノカプロン酸、アルミニウムクロルヒドロキシル
アラントイン、ジヒドロコレステロール、グリチルリチ
ン塩類、グリチルレチン酸、グリセロホスフェート、ク
ロロフィル、塩化ナトリウム、カロペプタイド、水溶性
無機リン酸化合物などの薬効成分を、単独で用いても2
種以上を併用してもよい。Bactericides such as chlorhexidine gluconate, cetylpyridinium chloride, and triclosan; enzymes such as dextranase, amylase, protease, mutanase, lysozyme, and lytic enzyme (Litech enzyme); sodium monofluorophosphate; Alkali metal monofluorophosphates such as potassium acid, fluorides such as sodium fluoride and stannous fluoride, vitamin derivatives, tranexamic acid and epsilon aminocaproic acid, aluminum chlorhydroxyallantoin, dihydrocholesterol, glycyrrhizin salts, glycyrrhetinic acid, glycerophosphate , Chlorophyll, sodium chloride, caropeptide, water-soluble inorganic phosphate compound, etc.
More than one species may be used in combination.
【0024】[0024]
【実施例】つぎに、実施例および比較例を示し、本発明
をさらに具体的に説明するが、本発明はこれらに限定さ
れるものではない。また、特にことわらない限り[%]
は重量%を示す。表1に示す成分を含有する、下記の歯
磨組成物を常法により調製し、経日安定性を評価した。Next, the present invention will be described more specifically with reference to examples and comparative examples, but the present invention is not limited to these examples. Unless otherwise stated, [%]
Indicates% by weight. The following dentifrice compositions containing the components shown in Table 1 were prepared by a conventional method, and the stability over time was evaluated.
【0025】 (練歯磨) 成分 配合量(%) 無水ケイ酸 15.0 カルボキシメチルセルロースナトリウム 2.0 ソルビット 60.0 パラヒドロキシ安息香酸メチル 0.2 サッカリンナトリウム 0.1 ラウリル硫酸ナトリウム 1.2 表1に示す成分(及び分量) 水 残部 生体活性ガラス 5.0 (SiO2/CaO;50/50%) 合計 100.0(Toothpaste) Ingredients Compounding amount (%) Silicic anhydride 15.0 Sodium carboxymethylcellulose 2.0 Sorbit 60.0 Methyl parahydroxybenzoate 0.2 Saccharin sodium 0.1 Sodium lauryl sulfate 1.2 Table 1 components shown (and amount) of water balance bioactive glass 5.0 (SiO 2 / CaO; 50 /50%) total 100.0
【0026】評価は下記に示す方法により行った。 (評価方法)練歯磨を調製後、0℃、室温、40℃にそ
れぞれチューブに充填し、放置した。3ヶ月後にチュー
ブから絞り出し、着色について下記に示す基準で評価を
行った。結果を表1に示す。 (評価基準) ○:調製直後と同じで着色なし。 △:調製後よりもやや着色している。 ×:調製直後よりもかなり着色している。The evaluation was performed by the following method. (Evaluation method) After the toothpaste was prepared, it was filled into tubes at 0 ° C, room temperature, and 40 ° C, respectively, and allowed to stand. Three months later, the tube was squeezed out of the tube, and the coloring was evaluated according to the following criteria. Table 1 shows the results. (Evaluation criteria) :: Same as immediately after preparation, no coloring. Δ: Slightly colored after preparation. ×: considerably colored than immediately after preparation.
【0027】[0027]
【表1】 [Table 1]
【0028】表1の結果より明らかなように、実施例は
比較例に対して、経時的に着色しない歯磨組成物である
ことが確認できた。As is clear from the results shown in Table 1, it was confirmed that the Example was a dentifrice composition that did not stain with time as compared with the Comparative Example.
【0029】 実施例6 練歯磨 成 分 配合量(%) 炭酸カルシウム 40.0 カルボキシメチルセルロースナトリウム 2.0 安息香酸ナトリウム 0.4 サッカリンナトリウム 0.1 ラウリル硫酸ナトリウム 1.2 ソルビット 25.0 ポリエチレングリコール 5.0 カルボン 0.2 メントン 0.1 メントール 0.7 香料 0.3 水 適量 生体活性ガラス 5.0 (SiO2/CaO/Na2O;45/30/25%) 合 計 100.0 (精製水で4倍に希釈した実施例6のpH:6.5)Example 6 Toothpaste Ingredients Content (%) Calcium carbonate 40.0 Sodium carboxymethylcellulose 2.0 Sodium benzoate 0.4 Sodium saccharin 0.1 Sodium lauryl sulfate 1.2 Sorbit 25.0 Polyethylene glycol 5. 0 carboxylic 0.2 menthone 0.1 menthol 0.7 perfume 0.3 water qs bioactive glass 5.0 (SiO 2 / CaO / Na2O ; 45/30/25%) total 100.0 (purified water 4 PH of Example 6 diluted 1: fold: 6.5)
【0030】実施例6の練歯磨は長期保存しても着色し
ない組成物であると認められた。また、成人永久歯エナ
メル質から約1×3mm2の切片をアクリル樹脂に包埋
し、この練歯磨と市販の歯ブラシを用いて5分間ブラッ
シングした後、全唾液中に、37℃にて12時間静置し
た。その成人永久歯をマイクロラジオグラフで観察した
ところ、エナメル質表面にハイドロキシアパタイト膜が
均一に約5μm形成されていることが認められた。The toothpaste of Example 6 was found to be a composition that did not discolor even after long-term storage. Also, a section of about 1 × 3 mm 2 from adult permanent tooth enamel was embedded in acrylic resin, brushed with this toothpaste and a commercially available toothbrush for 5 minutes, and then left in whole saliva at 37 ° C. for 12 hours. did. Observation of the adult permanent teeth with a microradiograph revealed that a hydroxyapatite film was uniformly formed on the surface of the enamel at about 5 μm.
【0031】 実施例7 洗口剤 成 分 配合量(%) グリセリン 15.0 アルコール 10.0 ポリオキシエチレン(60)硬化ヒマシ油 1.0 クエン酸ナトリウム(pH調整剤) 0.05 ステビア 0.02 アネトール 0.01 メントール 0.09 香料 0.02 水 適量 生体活性ガラス 5.0 (SiO2/CaO/Na20/F;50/20/20/10%) 合 計 100.0 (pH7.0)Example 7 Mouthwash Component Ingredient Content (%) Glycerin 15.0 Alcohol 10.0 Polyoxyethylene (60) hydrogenated castor oil 1.0 Sodium citrate (pH adjuster) 0.05 Stevia 0.0 02 anethole 0.01 menthol 0.09 perfume 0.02 water qs bioactive glass 5.0 (SiO 2 / CaO / Na 2 0 / F; 50/20/20/10%) total 100.0 (pH 7. 0)
【0031】実施例7も、経時的に着色することもな
く、又、人工唾液中で結晶が析出し、それを赤外分光法
およびX線回折で分析したところ、ハイドロキシアパタ
イトと確認された。In Example 7, no coloration occurred over time, and crystals were precipitated in artificial saliva. The crystals were analyzed by infrared spectroscopy and X-ray diffraction, and were confirmed to be hydroxyapatite.
【0032】[0032]
【発明の効果】本発明によれば、短時間で、かつ均一に
歯牙のエナメル質表面にハイドロキシアパタイト膜を形
成し、且つ、経時的に着色しない安定な口腔用組成物を
提供することができる。According to the present invention, it is possible to provide a stable oral composition which forms a hydroxyapatite film on the enamel surface of a tooth in a short time and uniformly and does not discolor over time. .
Claims (6)
アネトール、カルボン、メントール、オイゲノール、シ
ネオール、メントン、サリチル酸メチルから選ばれる1
種又は2種以上を配合することを特徴とする口腔用組成
物。1. One or more bioactive glasses,
1 selected from anethole, carvone, menthol, eugenol, cineole, menthone, methyl salicylate
A composition for the oral cavity, characterized by blending two or more species.
量%のSiO2および10〜60重量%のCaOを含有
する生体活性ガラスを配合する請求項1記載の口腔用組
成物。2. The composition for oral cavity according to claim 1, wherein the composition of the bioactive glass contains a bioactive glass containing 20 to 70% by weight of SiO 2 and 10 to 60% by weight of CaO.
量%のSiO2、10〜50重量%のCaO、および0
〜30重量%のNa2Oを含有する生体活性ガラスを配
合する請求項1、及び2項の何れか1項に記載の口腔用
組成物。3. The composition of the bioactive glass comprises 30-60% by weight of SiO 2 , 10-50% by weight of CaO, and 0% by weight.
Claim 1 to incorporate bioactive glass containing 30 wt% of Na 2 O, and oral composition according to any one of two terms.
2O、Li2O、TiO2、Al2O3、MgO、B2O3、
ZrO2、およびFよりなる群から選らばれる1種また
は2種以上の無機化合物を含有する請求項1、2、及び
3項のいずれか1項記載の口腔用組成物。4. The bioactive glass further comprises PTwoOFive, K
TwoO, LiTwoO, TiOTwo, AlTwoOThree, MgO, BTwoOThree,
ZrOTwo, And one selected from the group consisting of F
Contains two or more inorganic compounds.
Item 4. The oral composition according to any one of Items 3 to 3.
50重量%である請求項1、2、3、及び4項のいずれ
か1項記載の口腔用組成物。5. The blending amount of the bioactive glass is 0.001 to 0.001.
The oral composition according to any one of claims 1, 2, 3, and 4, which is 50% by weight.
3、4及び5項のいずれか1項記載の口腔用組成物。6. The method according to claim 1, wherein the pH is 3 to 10.
6. The oral composition according to any one of items 3, 4, and 5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP35203496A JPH10167941A (en) | 1996-12-10 | 1996-12-10 | Composition for oral cavity containing biologically active glass |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP35203496A JPH10167941A (en) | 1996-12-10 | 1996-12-10 | Composition for oral cavity containing biologically active glass |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH10167941A true JPH10167941A (en) | 1998-06-23 |
Family
ID=18421334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP35203496A Pending JPH10167941A (en) | 1996-12-10 | 1996-12-10 | Composition for oral cavity containing biologically active glass |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH10167941A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012509894A (en) * | 2008-11-25 | 2012-04-26 | ザ プロクター アンド ギャンブル カンパニー | Oral care composition having fused silica |
| CN110436778A (en) * | 2019-07-26 | 2019-11-12 | 深圳阳光环球玻璃有限公司 | A kind of orthopaedics reparation bioactive glass material preparation method |
| CN115429709A (en) * | 2022-07-12 | 2022-12-06 | 广州鸿博生物科技有限公司 | Preparation method of toothpaste containing bioactive glass |
-
1996
- 1996-12-10 JP JP35203496A patent/JPH10167941A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012509894A (en) * | 2008-11-25 | 2012-04-26 | ザ プロクター アンド ギャンブル カンパニー | Oral care composition having fused silica |
| JP2012509898A (en) * | 2008-11-25 | 2012-04-26 | ザ プロクター アンド ギャンブル カンパニー | Whitening composition with fused silica |
| CN110436778A (en) * | 2019-07-26 | 2019-11-12 | 深圳阳光环球玻璃有限公司 | A kind of orthopaedics reparation bioactive glass material preparation method |
| CN110436778B (en) * | 2019-07-26 | 2021-12-07 | 深圳阳光环球玻璃有限公司 | Preparation method of bioactive glass material for orthopedic repair |
| CN115429709A (en) * | 2022-07-12 | 2022-12-06 | 广州鸿博生物科技有限公司 | Preparation method of toothpaste containing bioactive glass |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2728391C (en) | Composition and method for enhancing fluoride uptake using bioactive glass | |
| JP2001516709A (en) | Methods and compositions for whitening teeth | |
| JPS58118509A (en) | Oral composition | |
| JP6755453B2 (en) | Toothpaste composition | |
| JP3816999B2 (en) | Bioactive glass-containing oral coating | |
| JP2002047157A (en) | Oral composition | |
| JPH1112142A (en) | Oral composition | |
| JPH1121219A (en) | Oral composition | |
| JPH10120540A (en) | Composition containing biologically active glass for oral cavity | |
| JP3623086B2 (en) | Bioactive glass-containing oral composition | |
| JPH10182393A (en) | Oral composition containing crystallized glass for living body activation | |
| JP3022039B2 (en) | Oral composition for preventing tooth coloring | |
| WO1998017236A1 (en) | Oral preparations containing biologically active crystallized glass | |
| JPH10139644A (en) | Oral cavity composition containing bioactive glass | |
| JPH10167941A (en) | Composition for oral cavity containing biologically active glass | |
| JPH1067627A (en) | Organism active glass-containing composition for oral cavity | |
| JPH08268855A (en) | Composition for oral cavity | |
| JPH08268854A (en) | Composition for oral cavity | |
| JP2001288061A (en) | Oral composition | |
| JP4257001B2 (en) | Oral composition | |
| JPH08245353A (en) | Oral composition | |
| JPH11130648A (en) | Oral composition | |
| JPH09301839A (en) | Biologically active crystallized glass-containing composition for oral cavity | |
| WO2021047900A1 (en) | Oral care composition | |
| EP4301320B1 (en) | Oral care composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Effective date: 20040524 Free format text: JAPANESE INTERMEDIATE CODE: A971007 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040608 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20041019 |